OppenheimerFunds, Inc. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2019$16,857,000
+73.1%
100,0000.0%0.02%
+50.0%
Q4 2018$9,739,000
-43.6%
100,0000.0%0.01%
-30.0%
Q3 2018$17,274,000
+23.8%
100,0000.0%0.02%
+17.6%
Q2 2018$13,954,000
+23.8%
100,0000.0%0.02%
+21.4%
Q1 2018$11,267,000
-52.2%
100,000
-44.0%
0.01%
-50.0%
Q4 2017$23,555,000
+132.1%
178,430
+78.4%
0.03%
+133.3%
Q3 2017$10,149,000
+1.2%
100,0000.0%0.01%0.0%
Q2 2017$10,025,000
-17.1%
100,0000.0%0.01%
-20.0%
Q1 2017$12,094,000
+8.2%
100,0000.0%0.02%
+7.1%
Q4 2016$11,175,000
-15.8%
100,0000.0%0.01%
-17.6%
Q3 2016$13,273,000
+44.9%
100,0000.0%0.02%
+41.7%
Q2 2016$9,157,000
+26.9%
100,0000.0%0.01%
+20.0%
Q1 2016$7,215,000
-48.0%
100,000
-50.0%
0.01%
+11.1%
Q4 2015$13,888,000
+52.0%
200,000
-83.3%
0.01%
-25.0%
Q3 2015$9,137,000
-25.6%
1,200,000
+1100.0%
0.01%
-14.3%
Q2 2015$12,284,000100,0000.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders